CymitQuimica logo
EGFR

EGFR

Gli inibitori del recettore del fattore di crescita epidermico (EGFR) sono composti che bloccano la segnalazione dell'EGFR, un recettore spesso sovraespresso in vari tipi di cancro e che svolge un ruolo cruciale nell'angiogenesi. Gli inibitori dell'EGFR sono utilizzati per prevenire la crescita tumorale e le metastasi interrompendo le vie che promuovono la formazione di vasi sanguigni nei tumori. Questi inibitori sono ampiamente utilizzati nella ricerca e nella terapia del cancro. Presso CymitQuimica, offriamo una vasta selezione di inibitori dell'EGFR di alta qualità per supportare la tua ricerca in oncologia e angiogenesi.

Trovati 594 prodotti di "EGFR"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • PROTAC EGFR degrader 2


    Potent PROTAC EGFR degrader 2; IC50: 4.0 nM, DC50: 36.51 nM; inhibits cell growth; for NTR-responsive synthesis.
    Formula:C58H72ClFN12O8S
    Colore e forma:Solid
    Peso molecolare:1151.78
  • BMS-599626 2HCL(714971-09-2 Free base)

    CAS:
    <p>BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative.</p>
    Formula:C27H29Cl2FN8O3
    Purezza:99.11%
    Colore e forma:Odour Solid
    Peso molecolare:603.47
  • Gefitinib N-oxide hydrochloride


    Gefitinib N-oxide hydrochloride is an N-oxide of EGFR inhibitor Gefitinib with IC50 of 2-37 nM.
    Formula:C22H24ClFN4O41·5HCl
    Colore e forma:Solid
    Peso molecolare:517.59
  • Timigutuzumab

    CAS:
    Timigutuzumab (GEXMab73) is a humanized monoclonal antibody designed to target ErbB2, showing potential application in cancer research [1].
    Colore e forma:Liquid
  • EP26


    EP26 is an orally active and potent inhibitor of EGFR and PD-L1, with IC50 values of 48.6 nM and 1.77 µM, respectively. It reduces the protein expression of p-EGFR and induces cell cycle arrest at the G0/G1 phase. EP26 shows potential for glioblastoma research.
    Formula:C42H42ClFN4O5
    Peso molecolare:736.28278
  • ARRY-380 (analog )

    CAS:
    ARRY-380 analog (HER2-Inhibitor-1) is a potent and selective HER2 inhibitor.
    Formula:C29H27N7O4S
    Purezza:99.82%
    Colore e forma:Solid
    Peso molecolare:569.63
  • Simotinib hydrochloride

    CAS:
    Simotinib hydrochloride: selective oral EGFR inhibitor, IC50 19.9 nM, potent anticancer agent.
    Formula:C25H27Cl2FN4O4
    Colore e forma:Solid
    Peso molecolare:537.41
  • HDS 029

    CAS:
    <p>HDS 029 has a wide range of applications in life science related research.</p>
    Formula:C17H11ClFN5O
    Colore e forma:Solid
    Peso molecolare:355.76
  • IBI-334


    <p>IBI-334 is a bispecific antibody targeting both B7-H3 and EGFR. It features an EGFR arm responsible for signal blocking, connected to a modified B7-H3 arm that ensures optimal affinity and binding. The antibody is afucosylated to enhance its antibody-dependent cellular cytotoxicity (ADCC) effects. IBI-334 is widely applicable in EGFR-driven solid tumors.</p>
    Colore e forma:Odour Liquid
  • OK2


    OK2, a specific inhibitor of the CCN2/EGFR interaction, effectively disrupts this interaction by binding to the CT domain of CCN2.
    Formula:C42H62N14O9
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:907.03
  • MS9427 TFA


    MS9427 TFA: PROTAC EGFR degrader, Kd 7.1 nM (WT), 4.3 nM (L858R), targets mutant EGFR, inhibits NSCLC cell growth, for cancer research.
    Formula:C50H59ClF4N8O14
    Colore e forma:Solid
    Peso molecolare:1107.5
  • Depatuxizumab MMAF


    <p>Depatuxizumab-MMAF, an antibody-drug conjugate (ADC), comprises an EGFR-targeted antibody linked to McMMAF and is utilized in glioblastoma research.</p>
    Colore e forma:Liquid
    Peso molecolare:148.24 kDa
  • DS06652923


    <p>DS06652923 is an orally active inhibitor targeting EGFR triple mutations. It exhibits growth-inhibitory effects on Ba/F3EGFRdel19/T90M/C795S cells, with a GI50 value of 9.4 nM. Additionally, DS06652923 induces tumor regression in the Ba/F3 syngeneic transplantation model.</p>
    Colore e forma:Odour Solid
  • PROTAC EGFR degrader 3

    CAS:
    Potent PROTAC EGFR degrader 3; excellent against H1975/HCC827 cells; lysosome-involved mutant degradation.
    Formula:C60H77N13O5S
    Colore e forma:Solid
    Peso molecolare:1092.4
  • AZ14240475


    AZ14240475 is a potent, selective, brain-penetrant inhibitor of EGFREx20Ins mutants (EGFREx20Ins mutants) with a pIC50 of 7.6, playing a significant role in cancer research.
    Formula:C23H15ClF2N6O2
    Colore e forma:Solid
    Peso molecolare:480.854
  • HER2/neu (654-662) GP2

    CAS:
    Phage display selected Affibody ligands for HER2/neu from a protein library based on a 58-residue Staphylococcal protein A Z domain.
    Formula:C42H77N9O11
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:884.11
  • JAK 3 inhibitor IV

    CAS:
    JAK 3 inhibitor IV (ZM 39923 hydrochloride) is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found to
    Formula:C16H19NO
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:241.33
  • Inetetamab


    Inetetamab is a recombinant humanized antibody targeting HER2 receptor domain IV, with anticancer activity, inducing pyroptosis in lung adenocarcinoma.
    Purezza:96.54% (SEC-HPLC) - 96.54% (SEC-HPLC)
    Colore e forma:Odour Liquid
  • EGFR-IN-162


    <p>EGFR-IN-162 (compound 20) is an effective EGFR inhibitor that enhances both early and late apoptosis (EGFR) as well as necrosis (necrosis). It shows potential for use in breast cancer research.</p>
    Formula:C27H31N3O2
    Colore e forma:Solid
    Peso molecolare:429.24163
  • Pertuzumab

    CAS:
    Pertuzumab (anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2
    Purezza:98.00%
    Colore e forma:Liquid
    Peso molecolare:148 kDa